Cleared Traditional

K022719 - PHYSICAL MONITORING REGISTRATION UNIT

K022719 is an FDA 510(k) clearance for PHYSICAL MONITORING REGISTRATION UNIT, manufactured by Maryrose Cusimano, Ph.D./Phil Reaston. The device is a Class 2 Neurology device with product code IKN cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K022719 · Maryrose Cusimano, Ph.D./Phil Reaston · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2002
Decision
90d
Days
Class 2
Risk

K022719 is an FDA 510(k) clearance for the PHYSICAL MONITORING REGISTRATION UNIT. Classified as Electromyograph, Diagnostic (product code IKN), Class II - Special Controls.

Submitted by Maryrose Cusimano, Ph.D./Phil Reaston (Sunrise, US). The FDA issued a Cleared decision on November 13, 2002 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 890.1375 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Maryrose Cusimano, Ph.D./Phil Reaston devices

FDA 510(k) Submission Details - K022719

510(k) Number K022719 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2002
Decision Date November 13, 2002
Days to Decision 90 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 148d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IKN Device Classification - Class 2, Special Controls

Product Code IKN Electromyograph, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.1375
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - IKN Electromyograph, Diagnostic

All 38
Devices cleared under the same product code (IKN) and FDA review panel - the closest regulatory comparables to K022719.
CERSR ELECTROMYOGRAPHY SYSTEM
K110048 · Spinematrix, Inc. · Jan 2011
XLTEK XCALIBUR EMG / LT, MODEL PK1P33, PK1059
K052112 · Excel Tech. , Ltd. · Oct 2005
NIM-PRS
K024316 · Medtronic Xomed, Inc. · Jan 2003
NEUROPACK MICRO, MODEL MED-9100A SERIES
K010590 · Nihon Kohden America, Inc. · Jun 2001
JE 2000
K993878 · Jack'S Electrodes · Feb 2000
CERSR ELECTROMYOGRAPHY SYSTEM
K990766 · Paraspinal Diagnostic Corp. · Aug 1999